A meta-analysis of the accuracy of prostate cancer studies which use magnetic resonance spectroscopy as a diagnostic tool

Korean Journal of Radiology

Volumn 9, Issue 5, 2008, Pages 432-438

  Wang, Peng ^a,d   Guo, You Min ^a   Liu, Min ^b   Qiang, Yong Qian ^a   Guo, Xiao Juan ^b   Zhang, Yi Li ^a   Duan, Xiao Yi ^a   Zhang, Qiu Juan ^a   Liang, Weifeng ^c  

^a Imaging Center   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

^d XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

Magnetic resonance (MR), spectroscopy; Meta analysis; Prostate carcinoma; Summary receiver operating characteristic curve (SROC)

Indexed keywords

DIAGNOSTIC AGENT;

ARTICLE; HUMAN; MALE; META ANALYSIS; METABOLISM; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PROSPECTIVE STUDY; PROSTATE TUMOR; ROC CURVE; SENSITIVITY AND SPECIFICITY;

HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 54349120782     PISSN: 12296929     EISSN: None     Source Type: Journal    
DOI: 10.3348/kjr.2008.9.5.432     Document Type: Article

References (29)

1. van Dorsten FA, van der Graaf M, Engelbrecht MR, van Leenders GJ, Verhofstad A, Rijpkema M, et al. Combined quantitative dynamic contrast-enhanced MR imaging and (1)H MR spectroscopic imaging of human prostate cancer. J Magn Reson Imaging 2004;20:279-287
2. Liu ZW, Xiang YB, Zhang W, Fang RR, Wan ZX, Sun L, et al. Incidence trends of prostate cancer in urban Shanghai (1973-1999). Chinese Journal of Health Statistics 2003;20:335-337
3. Scardino PT. The Gordon Wilson Lecture. Natural history and treatment of early stage prostate cancer. Trans Am Clin Climatol Assoc 2000;111:201-241
4. Carter HB, Partin AW. Diagnosis and staging of prostate cancer. In: Walsh PC, Retik AB, Vaughan ED Jr, Wein AJ (eds) Campbell's urology, 7th ed. Philadelphia: Saunders, 1998;III:2519-2537
5. Kurhanewicz J, Vigneron DB, Nelson SJ, Hricak H, MacDonald JM, Konety B, et al. Citrate as an in vivo marker to discriminate prostate cancer from benign prostatic hyperplasia and normal prostate peripheral zone: detection via localized proton spectroscopy. Urology 1995;45:459-466
6. Kurhanewicz J, Vigneron DB, Hricak H, Narayan P, Carroll P, Nelson SJ. Three-dimensional H-1 MR spectroscopy imaging of the in situ human prostate with high (0.24-0.7 cm) spatial resolution. Radiology 1996;198:795-805
7. Clark TJ, Mann CH, Shan N, Khan KS, Song F, Gupta JK. Accuracy of outpatient endometrial biopsy in the diagnosis of endometrial cancer: a systematic quantitative review. BJOG 2002;109:313-321
8. McAlister FA, Straus SE, Sackett DL. Why we need large, simple studies of the clinical examination: the problem and a proposed solution. Lancet 1999;354:1721-1724
9. Liu M, Guo YM, Guo XJ, Chen M, Zhang SJ. Evaluation of 99m Tc-MIBI scinti-mammorgraphy in the diagnosis of primary breast cancer: a meta-analysis. Chinese J Evidence-Based Medicine 2005;5:536-542
10. Moses LE, Shapiro D, Littenberg B. Combining independent studies of a diagnostic test into a summary ROC curve: data analytic approaches and some additional considerations. Stat Med 1993;12:1293-1316
11. Mueller-Lisse UG, Vigneron DB, Hricak H, Swanson MG, Carroll PR, Bessette A, et al. Localized prostate cancer: effect of hormone deprivation therapy measured by using combined three-dimensional 1H MR spectroscopy and MR imaging: clinicopathologic case-controlled study. Radiology 2001;221:380-390
12. Jung JA, Coakley FV, Vigneron DB, Swanson MG, Qayyum A, Weinberg V, et al. Prostate depiction at endorectal MR spectroscopic imaging: investigation of a standardized evaluation system. Radiology 2004;233:701-708
13. Wefer AE, Hricak H, Vigneron DB, Coakley FV, Lu Y, Wefer J, et al. Sextant localization of prostate cancer: comparison of sextant biopsy, magnetic resonance imaging and magnetic resonance spectroscopic imaging with step section histology. J Urol 2000;164:400-404
14. Scheidler J, Hricak H, Vigneron DB, Yu KK, Sokolov DL, Huang LR, et al. Prostate cancer: localization with threedimensional proton MR spectroscopic imaging clinicopathologic study. Radiology 1999;213:473-480
15. Kyle KY, Juergen S, Hedvig H, Daniel BV, Charles JZ, Ryan GM, et al. Prostate cancer: prediction of extracapsular extentsion with endorectal MR imaging and three-dimensional proton MR spectroscopic imaging. Radiology 1999;213:481-488
16. Yuen JS, Thng CH, Tan PH, Khin LW, Phee SJ, Xiao D, et al. Endorectal magnetic resonance imaging and spectroscopy for the detection of tumor foci in men with prior negative transrectal ultrasound prostate biopsy. J Urol 2004;171:1482-1486
17. Prando A, Kurhanewicz J, Borges AP, Oliveira EM Jr, Figueiredo E. Prostatic biopsy directed with endorectal MR spectroscopic imaging findings in patients with elevated prostate specific antigen levels and prior negative biopsy findings: early experience. Radiology 2005;236:903-910
18. Liu GJ, Wu TX. Summary ROC curve-diagnostic test method of Meta-analysis. Chin J Evidence-Based Medicine 2003;3:41-44
19. Ikonen S, Kivisaari L, Tervahartiala P, Vehmas T, Taari K, Rannikko S. Prostate MR imaging. Accuracy in differentiating cancer from other prostatic disorders. Acta Radiol 2001;42:348-354
20. Hricak H, White S, Vigneron D, kurhanewicz J, Kosco A, Levin D, et al. Carcinoma of the prostate gland: MR imaging with pelvic phased-array coils versus integrated endorectal-pelvic phased-array coils. Radiology 1994;193:703-709
21. Jager GJ, Severens JL, Thornbury JR, de La Rosettee JJ, Ruijs SH, Barentsz JO. Prostate cancer staging: should MR imaging be used? A decision analytic approach. Radiology 2000;215:445-451
22. Filip GC, Hedvig H, Robert RH. Pretreatment evaluation of prostate cancer. Role of MR imaging and 1H MR spectroscopy. Radiographics 2004;24:167-180
23. Wefer AE, Hricak H, Vigneron DB, Coakley FV, Lu Y, Wefer J, et al. Sextant localization of prostate cancer: comparison of sextant biopsy, magnetic resonance imaging and magnetic resonance spectroscopic imaging with step section histology. J Urol 2000;164:400-404
24. Cookson MS, Fleshner NE, Soloway SM, Fair WR. Correlation between Gleason score of needle biopsy and radical prostatectomy specimen: accuracy and clinical implications. J Urol 1997;157:559-562
25. Zakian KL, Sircar K, Hricak H, Chen HN, Shukla-Dave A, Eberhardt S, et al. Correlation of proton MR spectroscopic imaging with gleason score based on step-section pathologic analysis after radical prostatectomy. Radiology 2005;234:804-814
26. Engelbrecht MR, Jager GJ, Laheij RJ, Verbeek AL, van Lier HJ, Barentsz JO. Local staging of prostate cancer using magnetic resonance imaging: a meta-analysis. Eur Radiol 2002;12:2294-2302
27. Wang XY, Zhou LP, Ding JP, Li FY, Shan GZ, Xiao JX, et al. Quantitative criteria of MR spectroscopy in the differential diagnosis of prostate cancer in China: preliminary study. Chin J Med Imaging Technol 2004;20:1150-1153
28. Li Yan, Li JJ, Cen S, Li CZ, Yu N, Zhao YM, et al. Quantitative analysis of MR spectroscopy in diagnosis of prostate cancer. Chin J Med Imaging Technol 2005;21:1915-1917
29. Qin HY, Bai RJ, Wang XM, Zhao X. The value of three-dimensional proton MR spectroscopic imaging in the differential diagnosis of prostate cancer in peripheral zone: preliminary study. J Med Imaging 2005;15:978-982